D. Pace and A. J. Pollard, Meningococcal disease: clinical presentation and sequelae, Vaccine, vol.30, issue.2, pp.3-9, 2012.

L. H. Harrison, S. I. Pelton, A. Wilder-smith, J. Holst, M. A. Safadi et al., The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease, Vaccine, vol.29, issue.18, pp.3363-71, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02083011

M. C. Maiden, M. J. Jansen-van-rensburg, J. E. Bray, S. G. Earle, S. A. Ford et al., MLST revisited: the gene-by-gene approach to bacterial genomics, Nat Rev Microbiol, vol.11, issue.10, pp.728-764, 2013.

, European Centre for Disease Prevention and Control. Factsheet about meningococcal disease, 2019.

N. G. Rouphael and D. S. Stephens, Neisseria meningitidis: biology, microbiology, and epidemiology, Methods Mol Biol, vol.799, pp.1-20, 2012.

, World Health Organization. Meningococcal Meningitis: World Health Organization, 2018.

R. Borrow, D. A. Caugant, M. Ceyhan, H. Christensen, E. C. Dinleyici et al., Meningococcal disease in the Middle East and Africa: findings and updates from the global meningococcal initiative, J Infect, vol.75, issue.1, pp.1-11, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-02013243

J. Findlow, Vaccines for the prevention of meningococcal capsular group B disease: what have we recently learned?, Hum Vaccin Immunother, vol.12, issue.1, pp.235-243, 2016.

R. Acevedo, X. Bai, R. Borrow, D. A. Caugant, J. Carlos et al., The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations, Expert Rev Vaccines, vol.18, issue.1, pp.15-30, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02013210

P. Krizova, M. Honskus, Z. Okonji, M. Musilek, and J. Kozakova, Surveillance of invasive meningococcal disease based on whole genome sequencing (WGS), Epidemiol Mikrobiol Imunol, vol.67, issue.2, pp.64-73, 2015.

P. Krizova and M. Honskus, Genomic surveillance of invasive meningococcal disease in the Czech Republic, PLoS One, vol.14, issue.7, p.219477, 2015.

R. Whittaker, J. G. Dias, M. Ramliden, C. Kodmon, A. Economopoulou et al., The epidemiology of invasive meningococcal disease in EU/EEA countries, Vaccine, vol.35, issue.16, pp.2034-2075, 2004.
URL : https://hal.archives-ouvertes.fr/pasteur-02055716

J. Carr, E. Plested, P. Aley, S. Camara, J. Maclennan et al., Be on the TEAM (Teenagers Against Meningitis): a clinical trial evaluating the impact of two licensed group B meningococcal vaccines on pharyngeal carriage of meningococcus in adolescents, Proceedings of the 21st International Pathogenic Neisseria Conference, pp.23-31, 2018.

, Analysis of the evolution of communicable diseases. Surveillance report, 2017.

M. Ceyhan, Y. Ozsurekci, N. Gurler, K. Oncel, E. Camcioglu et al., Bacterial agents causing meningitis during 2013-2014 in Turkey: a multi-center hospital-based prospective surveillance study, Hum Vaccin Immunother, vol.12, issue.11, pp.2940-2945, 2016.

M. Ceyhan, N. Gurler, Y. Ozsurekci, M. Keser, A. E. Aycan et al., Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae type B and Streptococcus Pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study, Hum Vaccin Immunother, vol.10, issue.9, pp.2706-2718, 2014.

, Russian Reference Center for Monitoring Bacterial Meningitis [Meningococcal infection and purulent bacterial meningitis in the Russian Federation, 2017.

, ??????????????? ???????? ? ??????? ????????????? ????????? ? ?????????? ????????? 2017 ???, 2018.

. Koroun, Invasive meningococcal disease (IMD) in Poland, 2018.

, National Center for Epidemiology The epidemiolgy of invasive meningococcal disease in Hungary, EPINFO, vol.23, issue.49, pp.593-601, 2016.

H. N. Kharkhal and L. P. Titov, Serogroup diversity and antibiotic susceptibility of Neisseria meningitidis : meningococcus infection monitoring in Belarus, Acta Microbiol Immunol Hung, vol.2019, pp.1-7

M. Ceyhan, Y. Ozsurekci, C. Bayhan, N. Gurler, E. Sali et al., The changing epidemiology of bacterial meningitis during 2015-2017 in Turkey: a hospital-based prospective surveillance study, Open Forum Infect Dis, vol.5, 2018.

S. V. Matosova, K. O. Mironov, and O. Y. Shipulina, The distribution of serogroups causing invasive forms of meningococcal infection in Moscow, Proceedings of the XI Annual Russian Congress of Infectious Diseases with International Participation, pp.1-3, 2018.

S. Matosova, K. Mironov, A. Platonov, O. Shipulina, G. Shipulin et al.,

, ??????????? -????????????? ?????????? ???????????? ???????? ?????????????? ????????? ?? ??????????? ?????, Infect Dis News, Opin Train, vol.7, issue.1, pp.93-102, 2018.

M. Krone, S. Gray, R. Abad, A. Skoczynska, P. Stefanelli et al., Increase of invasive meningococcal serogroup W disease in Europe, Euro Surveill, vol.24, issue.14, 2013.

S. Bukovski, P. Vacca, A. Anselmo, I. Knezovic, C. Fazio et al., Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, J Med Microbiol, vol.65, issue.9, pp.1013-1032, 2009.

M. Honskus, Z. Okonji, M. Musilek, J. Kozakova, and P. Krizova, Whole genome sequencing of Neisseria meningitidis W isolates from the Czech Republic recovered in 1984-2017, PLoS One, vol.13, issue.9, p.199652, 2018.

C. Vaccinology-society, Czech Vaccinology Society recommendation for vaccination against invasive meningococcal disease, 2018.

, The federal service on customers' rights protection and human well-being surveillance prevention of meningococcus infection: the federal service on customers' rights protection and human well-being surveillance, 2018.

, National Public Health Centre. National Guideline of Vaccinaton (Hungarian), p.29, 2019.

A. Skoczynska, I. Wasko, A. Kuch, M. Kadlubowski, A. Golebiewska et al., A decade of invasive meningococcal disease surveillance in Poland, PLoS One, vol.8, issue.8, p.71943, 2013.

D. M. Granoff, S. Pelton, and L. H. Harrison, Meningococcal vaccines, pp.388-418, 2012.

A. Khatami and A. J. Pollard, The epidemiology of meningococcal disease and the impact of vaccines, Exp Rev Vaccines, vol.9, issue.3, pp.285-98, 2010.

A. J. Pollard, K. P. Perrett, and P. C. Beverley, Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines, Nat Rev Immunol, vol.9, pp.213-233, 2009.

M. C. Maiden, A. B. Ibarz-pavon, R. Urwin, S. J. Gray, N. J. Andrews et al., Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity, J Infect Dis, vol.197, issue.5, pp.737-780, 2008.

E. Miller, D. Salisbury, and M. Ramsay, Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story, Vaccine, vol.20, issue.1, pp.58-67, 2001.

D. M. Daugla, J. P. Gami, K. Gamougam, N. Naibei, L. Mbainadji et al., Effect of a serogroup a meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study, Lancet, vol.383, issue.9911, pp.40-47, 2014.

K. Gamougam, D. M. Daugla, J. Toralta, C. Ngadoua, F. Fermon et al., Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Emerg Infect Dis, vol.21, issue.1, pp.115-133, 2013.

P. A. Kristiansen, A. K. Ba, I. Sanou, R. Ouédraogo, L. Sangaré et al., Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac, BMC Infect Dis, vol.14, issue.663, pp.1-11, 2014.

P. A. Kristiansen, F. Diomande, A. K. Ba, I. Sanou, A. S. Ouedraogo et al., Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity, Clin Infect Dis, vol.56, issue.3, pp.354-63, 2013.

R. C. Read, D. Baxter, D. R. Chadwick, S. N. Faust, A. Finn et al., Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial, Lancet, vol.384, issue.9960, pp.2123-2154, 2014.

P. Health-england, Any Impact on serogroup W? (up to 2016/17), 2018.

W. H. Chen, K. M. Neuzil, C. R. Boyce, M. F. Pasetti, M. K. Reymann et al., Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study, Lancet Infect Dis, vol.18, issue.10, pp.1088-96, 2018.

J. Finne, M. Leinonen, and P. H. Makela, Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis, Lancet, vol.2, issue.8346, pp.355-362, 1983.

F. A. Wyle, M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper et al., Immunologic response of man to group B meningococcal polysaccharide, J Infect Dis, vol.126, issue.5, pp.514-535, 1972.

J. Holst, P. Oster, R. Arnold, M. V. Tatley, L. M. Naess et al., Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future, Hum Vaccin Immunother, vol.9, issue.6, pp.1241-53, 2013.

J. Sevestre, E. Hong, V. Delbos, A. Terrade, E. Mallet et al., Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: lessons of the Normandy campaign, Vaccine, vol.35, issue.32, pp.4029-4062, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-02013259

M. Pizza, V. Scarlato, V. Masignani, M. M. Giuliani, B. Aricò et al., Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing, Science, vol.20, issue.0, pp.1816-1836

. Emc, . Trumenba, and . Smpc, , 2019.

, Bexsero meningococcal group B vaccine for injection in pre-filled syringe, SmPC, 2019.

U. Vogel, M. K. Taha, J. A. Vazquez, J. Findlow, H. Claus et al., Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment, Lancet Infect Dis, vol.13, issue.5, pp.416-441, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02093031

J. A. Bettinger, D. W. Scheifele, S. A. Halperin, W. Vaudry, J. Findlow et al., Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB), Vaccine, vol.32, issue.1, pp.124-154, 2013.

L. K. Mcneil, R. Donald, A. Gribenko, R. French, N. Lambert et al., Predicting the susceptibility of meningococcal serogroup B isolates to bactericidal antibodies elicited by bivalent rLP2086, a novel prophylactic vaccine, MBio, vol.9, issue.2, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01950865

G. Tzanakaki, E. Hong, K. Kesanopoulos, A. Xirogianni, S. Bambini et al., Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine, BMC Microbiol, vol.14, p.111, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-00990250

I. Wasko, E. Hong, D. Paola, R. Stella, M. Moschioni et al., High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland, Vaccine, vol.34, issue.4, pp.510-525, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-02060307

E. Kim, S. Paulos, G. Carlone, B. Plikaytis, A. Cohn et al., Meningococcal antigen typing system (MATS) based coverage prediction for the 4CMenB vaccine in United States, Proceedings of the 18th International Pathogenic Neisseria Conference, pp.9-14, 2012.

H. M. Soeters, M. Whaley, A. , N. Kanadanian, K. V. Macneil et al., Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a College-Rhode Island, Clin Infect Dis, vol.64, issue.8, pp.1115-1137, 2015.

H. S. Marshall, M. Mcmillan, A. Koehler, A. Lawrence, J. M. Maclennan et al., B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents, BMJ Open, vol.8, issue.7, p.20988, 2018.

H. Marshall, M. Mcmillan, A. Koehler, A. Lawrence, J. Maclennan et al., A cluster randomised controlled trial in senior school students to assess the impact of 4CMenB on N. meningitidis carriage and determine any herd protection, Proceedings of the 21st International Pathogenic Neisseria Conference, pp.23-31, 2018.

L. Ostergaard, T. Vesikari, J. Absalon, J. Beeslaar, B. J. Ward et al., A bivalent meningococcal B vaccine in adolescents and young adults, N Engl J Med, vol.377, issue.24, pp.2349-62, 2017.

M. E. Santolaya, M. L. O'ryan, M. T. Valenzuela, V. Prado, R. Vergara et al., Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study, Lancet, vol.379, issue.9816, pp.617-641, 2012.

T. Vesikari, S. Esposito, R. Prymula, E. Ypma, I. Kohl et al., Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials, Lancet, vol.381, issue.9869, pp.825-860, 2013.

S. Parikh, K. Beebeejaun, H. Campbell, S. Ribeiro, C. Ward et al., Early evidence of effectiveness against group B meningococcal disease and population impact of a reduced infant schedule with 4CMenB vaccine in England, Lancet, vol.338, pp.2775-82, 2016.

P. Bryan, S. Seabroke, J. Wong, K. Donegan, E. Webb et al., Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study, Lancet Child Adolesc Health, vol.2, issue.6, pp.395-403, 2018.

S. L. Block, L. Szenborn, W. Daly, T. Jackowska, D. 'agostino et al., A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: results of a phase 2 randomized, controlled trial, Vaccine, vol.33, issue.21, pp.2500-2510, 2015.

R. M. Mulhall, D. Bennett, R. Cunney, R. Borrow, J. Lucidarme et al., Potential coverage of the 4CMenB vaccine against invasive serogroup B Neisseria meningitidis isolated from 2009 to 2013 in the Republic of, Ireland. mSphere, vol.3, issue.4, 2018.

J. Donnelly, D. Medini, G. Boccadifuoco, A. Biolchi, J. Ward et al., Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines, Proc Natl Acad Sci, vol.107, issue.45, pp.19490-19495, 2010.

A. Muzzi, A. Brozzi, L. Serino, M. Bodini, R. Abad et al., Genetic meningococcal antigen typing system (gMATS): a genotyping tool that predicts 4CMenB strain coverage worldwide, Vaccine, vol.37, issue.7, pp.991-1001, 2000.
URL : https://hal.archives-ouvertes.fr/pasteur-02013229

C. Brehony, C. Rodrigues, R. Borrow, A. Smith, R. Cunney et al., Distribution of Bexsero(R) antigen sequence types (BASTs) in invasive meningococcal disease isolates: implications for immunisation, Vaccine, vol.34, issue.39, pp.4690-4697, 2016.

G. Frosi, A. Biolchi, L. Sapio, M. Rigat, F. Gilchrist et al., Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage, Vaccine, vol.31, issue.43, pp.4-96, 2013.

A. Antignac, I. G. Boneca, J. C. Rousselle, A. Namane, J. P. Carlier et al., Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G, J Biol Chem, vol.278, issue.34, pp.31529-31564, 2003.

A. Backman, P. Orvelid, J. A. Vazquez, O. Skold, and P. Olcen, Complete sequence of a beta-lactamase-encoding plasmid in Neisseria meningitidis, Antimicrob Agents Chemother, vol.20, issue.0, pp.210-222

P. Botha, Penicillin-resistant Neisseria meningitidis in southern Africa, Lancet, vol.1, p.54, 1988.

J. R. Dillon and M. Pauze, Introductory address: resistance to antimicrobial agents. What next for Neisseria gonorrhoeae?, Sex Transm Dis, vol.11, issue.4, pp.353-362, 1984.

D. Fontanals, V. Pineda, I. Pons, and J. C. Rojo, Penicillin-resistant beta-lactamase producing Neisseria meningitidis in Spain, Eur J Clin Microbiol Infect Dis, vol.8, issue.1, pp.90-91, 1989.

M. C. Roberts and J. S. Knapp, Transfer of beta-lactamase plasmids from Neisseria gonorrhoeae to Neisseria meningitidis and commensal Neisseria species by the 25.2-megadalton conjugative plasmid, Antimicrob Agents Chemother, vol.32, issue.9, pp.1430-1432, 1988.

J. A. Vazquez, A. M. Enriquez, L. De-la-fuente, S. Berron, and M. Baquero, Isolation of a strain of beta-lactamase-producing Neisseria meningitidis in Spain, Eur J Clin Microbiol Infect Dis, vol.15, issue.2, pp.181-183, 1996.

R. Tsang, T. Ahmad, S. Tyler, B. Lefebvre, S. L. Deeks et al., Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease, Int J Infect Dis, vol.69, pp.55-62, 2018.

E. Hong, A. E. Deghmane, and M. K. Taha, Acquisition of beta-lactamase by Neisseria meningitidis through possible horizontal gene transfer, Antimicrob Agents Chemother, vol.62, issue.9, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01950880

H. Claus, M. Krone, and T. Lâm, Vogel U First invasive meningococcal isolate expressing a betalactamase in Germany, Proceedings of the 15th European Meningococcal and, p.35, 2019.

M. K. Taha, J. A. Vazquez, E. Hong, D. E. Bennett, S. Bertrand et al., Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis, Antimicrob Agents Chemother, vol.51, issue.8, pp.2784-92, 2007.

A. E. Deghmane, E. Hong, and M. K. Taha, Emergence of meningococci with reduced susceptibility to third-generation cephalosporins, J Antimicrob Chemother, vol.72, issue.1, pp.95-103, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-02013247

K. S. Murakami, S. Masuda, E. A. Campbell, O. Muzzin, and S. A. Darst, Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex, Science, vol.296, issue.5571, pp.1285-90, 2002.

E. Hong, T. Hedberg, S. Abad, R. Fazio, C. Enriquez et al., Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin, Antimicrob Agents Chemother, vol.57, issue.4, pp.1961-1965, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02089320

M. K. Taha, S. T. Hedberg, M. Szatanik, E. Hong, C. Ruckly et al., Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing, Antimicrob Agents Chemother, vol.54, issue.9, pp.3651-3659, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-02085459

S. Singhal, K. Purnapatre, V. Kalia, S. Dube, D. Nair et al., Ciprofloxacin-resistant Neisseria meningitidis, Emerg Infect Dis, vol.13, issue.10, pp.1614-1630, 2007.

D. Nair, R. Dawar, M. Deb, M. R. Capoor, S. Singal et al., Outbreak of meningococcal disease in and around, Epidemiol Infect, vol.20, issue.4, pp.570-576, 2009.

S. Negi, S. Grover, S. Rautela, D. Rawat, S. Gupta et al., Direct detection and serogroup characterization of Neisseria meningitidis from outbreak of meningococcal meningitis in Delhi, Iran J Microbiol, vol.2, issue.2, pp.73-82, 2010.

B. Zhu, Y. Fan, Z. Xu, L. Xu, P. Du et al., Genetic diversity and clonal characteristics of ciprofloxacin-resistant meningococcal strains in China, J Med Microbiol, vol.63, pp.1411-1429, 2014.

M. Chen, Q. Guo, Y. Wang, Y. Zou, G. Wang et al., Shifts in the antibiotic susceptibility, serogroups, and clonal complexes of Neisseria meningitidis in shanghai, china: a time trend analysis of the pre-quinolone and quinolone eras, PLoS Med, vol.12, issue.6, p.1001838, 2015.

J. Lucidarme, D. M. Hill, H. B. Bratcher, S. J. Gray, M. Du-plessis et al., Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage, J Infect, vol.71, issue.5, pp.544-52, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-02013265

L. Eriksson, S. T. Hedberg, S. Jacobsson, H. Fredlund, P. Molling et al., Whole-genome sequencing of emerging invasive Neisseria meningitidis serogroup W in sweden, J Clin Microbiol, vol.56, issue.4, pp.1409-1410, 2018.

E. Hong, A. S. Barret, A. Terrade, M. Denizon, D. Antona et al., Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France, J Infect, vol.76, issue.2, pp.149-58, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01950885

M. J. Knol, S. Hahné, J. Lucidarme, H. Campbell, H. E. De-melker et al., Temporal associations between national outbreaks of meningococcal serogroup W and c disease in the Netherlands and England: an observational cohort study, Lancet Publ Health, vol.2, issue.10, pp.473-82, 2017.

H. Findlow, H. Campbell, J. Lucidarme, N. Andrews, E. Linley et al., Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, Euro Surveill, vol.16, issue.1, 1998.

J. Lucidarme, A. Lekshmi, S. R. Parikh, J. E. Bray, D. M. Hill et al., Frequent capsule switching in 'ultra-virulent' meningococci -Are we ready for a serogroup B ST-11 complex outbreak?, J Infect, vol.75, issue.2, pp.95-103, 2017.

, Defeating meningitis by 2030, Proceedings of the First Meeting of the Technical Taskforce, 2018.

K. C. Ma, M. Unemo, S. Jeverica, R. D. Kirkcaldy, H. Takahashi et al., Genomic characterization of urethritis-associated Neisseria meningitidis shows that a wide range of N. meningitidis strains can cause urethritis, J Clin Microbiol, vol.55, issue.12, pp.3374-83, 2017.

T. A. Folaranmi, C. B. Kretz, H. Kamiya, J. R. Macneil, M. J. Whaley et al., Increased risk for meningococcal disease among men who have sex with men in the United States, Clin Infect Dis, vol.65, issue.5, pp.756-63, 2012.

M. K. Taha, H. Claus, M. Lappann, F. J. Veyrier, A. Otto et al., Evolutionary events associated with an outbreak of meningococcal disease in men who have sex with men, PLoS One, vol.11, issue.5, p.154047, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01351740

L. Aubert, M. Taha, N. Boo, L. Strat, Y. Deghmane et al., Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region, Euro Surveill, vol.20, issue.3, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-02060707

U. Marcus, U. Vogel, A. Schubert, H. Claus, J. Baetzing-feigenbaum et al., A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, Euro Surveill, vol.18, issue.28, 2012.

A. Miglietta, C. Fazio, A. Neri, P. Pezzotti, F. Innocenti et al., Interconnected clusters of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11), involving bisexuals and men who have sex with men, with discos and gay-venues hotspots of transmission, Euro Surveill, vol.23, issue.34, 2015.

J. A. Bazan, A. S. Peterson, R. D. Kirkcaldy, E. C. Briere, C. Maierhofer et al., Notes from the field: increase in Neisseria meningitidis-Associated urethritis among men at two sentinel clinics, MMWR Morb Mortal Wkly Rep, vol.65, issue.21, pp.550-552, 2015.

E. Toh, D. Gangaiah, B. E. Batteiger, J. A. Williams, J. N. Arno et al., Neisseria meningitidis ST11 complex isolates associated with nongonococcal urethritis, Emerg Infect Dis, vol.23, issue.2, pp.336-345, 2015.

Y. L. Tzeng, J. A. Bazan, A. N. Turner, X. Wang, A. C. Retchless et al., Emergence of a new Neisseria meningitidis clonal complex 11 lineage 11.2 clade as an effective urogenital pathogen, Proc Natl Acad Sci, vol.114, issue.16, pp.4237-4279, 2017.

A. C. Retchless, C. B. Kretz, H. Y. Chang, J. A. Bazan, A. J. Abrams et al., Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles, BMC Genomics, vol.19, issue.1, p.176, 2018.

J. A. Bazan, A. N. Turner, R. D. Kirkcaldy, A. C. Retchless, C. B. Kretz et al., Large cluster of Neisseria meningitidis urethritis in Columbus, Clin Infect Dis, vol.65, issue.1, pp.92-101, 2015.

J. A. Bazan, W. Roberts, M. Soge, O. O. Torrone, E. A. Dennison et al., Rapid increase in gonorrhea cases with reduced susceptibility to azithromycin in Columbus, Sex Transm Dis, vol.45, issue.2, pp.5-6, 2018.

Y. L. Tzeng, Z. Berman, E. Toh, J. A. Bazan, A. N. Turner et al., Heteroresistance to the model antimicrobial peptide polymyxin B in the emerging Neisseria meningitidis lineage 11.2 urethritis clade: mutations in the pilMNOPQ operon, Mol Microbiol, vol.111, issue.1, pp.254-68, 2019.

, Vaccine preventable diseases surveillance standards: World Health Organization, 2018.

, World Health Organization. Meningococcus: World Health Organization, 2018.

D. A. Caugant and M. C. Maiden, Meningococcal carriage and disease-population biology and evolution, Vaccine, vol.27, issue.2, pp.64-70, 2009.

H. Christensen, M. May, L. Bowen, M. Hickman, and C. L. Trotter, Meningococcal carriage by age: a systematic review and meta-analysis, Lancet Infect Dis, vol.10, issue.12, pp.853-61, 2010.

K. A. Cartwright, J. M. Stuart, D. M. Jones, and N. D. Noah, The stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica, Epidemiol Infect, vol.99, issue.3, pp.591-601, 1987.

S. Fernandez, L. Arreaza, I. Santiago, A. Malvar, S. Berron et al., Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain. Epidemiol Infect, vol.123, issue.3, pp.349-57, 1999.

J. Kremastinou, G. Tzanakaki, S. Levidiotou, F. Markou, E. Themeli et al., Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece, FEMS Immunol Med Microbiol, vol.39, issue.1, pp.23-32, 2003.

O. O. Bilukha and N. Rosenstein, Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices (ACIP), MMWR Recomm Rep, vol.54, pp.1-21, 2005.

P. B. Imrey, L. A. Jackson, P. H. Ludwinski, . England-ac-3rd, G. A. Fella et al., Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak, J Clin Microbiol, vol.33, issue.12, pp.3133-3140, 1995.

K. R. Neal, J. S. Nguyen-van-tam, J. N. Slack, R. C. Madeley, R. J. Ait-tahar et al., Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study, BMJ, vol.20, issue.0, pp.846-855

D. A. Caugant, G. Tzanakaki, and P. Kriz, Lessons from meningococcal carriage studies, FEMS Microbiol Rev, vol.31, issue.1, pp.52-63, 2007.

P. Kriz, M. Bobak, and B. Kriz, Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study, Arch Dis Child, vol.83, issue.2, pp.117-138, 2000.

J. Figueroa, J. Andreoni, and P. Densen, Complement deficiency states and meningococcal disease, Immunol Res, vol.12, issue.3, pp.295-311, 1993.

P. Hillmen, N. S. Young, J. Schubert, R. A. Brodsky, G. Socie et al., The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N Engl J Med, vol.355, issue.12, pp.1233-1276, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00599451

S. Misawa, S. Kuwabara, Y. Sato, N. Yamaguchi, K. Nagashima et al., Safety and efficacy of eculizumab in Guillain-Barre syndrome: a multicentre, double-blind, randomised phase 2 trial, Lancet Neurol, vol.17, issue.6, pp.519-548, 2018.

C. M. Nester and P. D. Brophy, Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases, Curr Opin Pediatr, vol.25, issue.2, pp.225-256, 2013.

R. Boutet, J. M. Stuart, E. B. Kaczmarski, S. J. Gray, D. M. Jones et al., Risk of laboratory-acquired meningococcal disease, J Hosp Infect, vol.49, issue.4, pp.282-286, 2001.

R. Brindle, P. Simani, R. Newnham, P. Waiyaki, and C. Gilks, No association between meningococcal disease and human immunodeficiency virus in adults in, Trans R Soc Trop Med Hyg, vol.85, issue.5, p.651, 1991.

R. D. Simmons, P. Kirwan, K. Beebeejaun, A. Riordan, R. Borrow et al., Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study, BMC Med, vol.13, p.297, 2015.

L. A. Lewis and S. Ram, Meningococcal disease and the complement system, Virulence, vol.5, issue.1, pp.98-126, 2014.

J. E. Figueroa and P. Densen, Infectious diseases associated with complement deficiencies, Clin Microbiol Rev, vol.4, issue.3, pp.359-95, 1991.

K. E. Sullivan, Emery and Rimoin's principles and practice of medical genetics, pp.1-13, 2013.

J. Rosain, E. Hong, C. Fieschi, P. V. Martins, E. Sissy et al., Strains responsible for invasive meningococcal disease in patients with terminal complement pathway deficiencies, J Infect Dis, vol.215, issue.8, pp.1331-1339, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-02013257

Y. Fukumori and T. Horiuchi, Terminal complement component deficiencies in Japan, Exp Clin Immunogenet, vol.15, issue.4, pp.244-252, 1998.

A. Haessig, J. F. Borel, P. Ammann, M. Thoeni, and R. Buetler,

, Pathol Microbiol, vol.27, pp.542-549, 1964.

R. Borrow, J. Findlow, S. Gray, S. Taylor, and E. Kaczmarski, Safe laboratory handling of Neisseria meningitidis, J Infect, vol.68, issue.4, pp.305-317, 2014.

J. J. Sejvar, D. Johnson, T. Popovic, J. M. Miller, F. Downes et al., Assessing the risk of laboratory-acquired meningococcal disease, J Clin Microbiol, vol.43, issue.9, pp.4811-4825, 2005.

J. Lucidarme, K. J. Scott, R. Ure, A. Smith, D. Lindsay et al., An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, Euro Surveill, vol.21, issue.45, 2015.

, World Health Organization. Health of refugees and migrants. Regional situation analysis, practices, experiences, lessons learned and ways forward, 2018.

E. Haelterman, M. Boelaert, C. Suetens, L. Blok, M. Henkens et al., Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp, Trop Med Int Health, vol.1, issue.3, pp.385-92, 1996.

P. Stefanelli, A. Neri, P. Vacca, D. Picicco, L. Daprai et al., Meningococci of serogroup X clonal complex 181 in refugee camps, Italy. Emerg Infect Dis, vol.23, issue.5, pp.870-872, 2017.

A. Ozkaya-parlakay, S. Kanik-yuksek, B. Gulhan, H. Tezer, and F. Altay, Unal-Sahin N . A refugee patient with meningococcal meningitis type B, Hum Vaccin Immunother, vol.14, issue.9, p.2329, 2018.

H. Tezer, A. Ozkaya-parlakay, S. Kanik-yuksek, B. Gulhan, and D. Guldemir, A Syrian patient diagnosed with meningococcal meningitis serogroup B, Hum Vaccin Immunother, vol.10, issue.8, p.2482, 2014.

D. Mipatrini, P. Stefanelli, S. Severoni, and G. Rezza, Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence, Pathog Glob Health, vol.111, issue.2, pp.59-68, 2017.

N. J. Oldfield, C. Cayrou, M. Aljannat, A. Al-rubaiawi, L. R. Green et al., Rise in group W meningococcal carriage in university students, United Kingdom. Emerg Infect Dis, vol.23, issue.6, pp.1009-1020, 2017.

M. Achtman, A. Van-der-ende, P. Zhu, I. S. Koroleva, B. Kusecek et al., Molecular epidemiology of serogroup a meningitis in Moscow, Emerg Infect Dis, vol.7, issue.3, pp.420-427, 1969.

. Kazakhstan and . Tmohotro, Department of public policy health statistics